Literature DB >> 28659473

Pace of Coreceptor Tropism Switch in HIV-1-Infected Individuals after Recent Infection.

Muhammad Shoaib Arif1, James Hunter1, Ana Rachel Léda1, Jean Paulo Lopes Zukurov2, Sadia Samer1, Michelle Camargo1, Juliana Galinskas1, Esper Georges Kallás3, Shirley Vasconcelos Komninakis1, Luiz Mario Janini2, Maria Cecilia Sucupira1, Ricardo Sobhie Diaz4.   

Abstract

HIV-1 entry into target cells influences several aspects of HIV-1 pathogenesis, including viral tropism, HIV-1 transmission and disease progression, and response to entry inhibitors. The evolution from CCR5- to CXCR4-using strains in a given human host is still unpredictable. Here we analyzed timing and predictors for coreceptor evolution among recently HIV-1-infected individuals. Proviral DNA was longitudinally evaluated in 66 individuals using Geno2pheno[coreceptor] Demographics, viral load, CD4+ and CD8+ T cell counts, CCR5Δ32 polymorphisms, GB virus C (GBV-C) coinfection, and HLA profiles were also evaluated. Ultradeep sequencing was performed on initial samples from 11 selected individuals. A tropism switch from CCR5- to CXCR4-using strains was identified in 9/49 (18.4%) individuals. Only a low baseline false-positive rate (FPR) was found to be a significant tropism switch predictor. No minor CXCR4-using variants were identified in initial samples of 4 of 5 R5/non-R5 switchers. Logistic regression analysis showed that patients with an FPR of >40.6% at baseline presented a stable FPR over time whereas lower FPRs tend to progressively decay, leading to emergence of CXCR4-using strains, with a mean evolution time of 27.29 months (range, 8.90 to 64.62). An FPR threshold above 40.6% determined by logistic regression analysis may make it unnecessary to further determine tropism for prediction of disease progression related to emergence of X4 strains or use of CCR5 antagonists. The detection of variants with intermediate FPRs and progressive FPR decay over time not only strengthens the power of Geno2pheno in predicting HIV tropism but also indirectly confirms a continuous evolution from earlier R5 variants toward CXCR4-using strains.IMPORTANCE The introduction of CCR5 antagonists in the antiretroviral arsenal has sparked interest in coreceptors utilized by HIV-1. Despite concentrated efforts, viral and human host features predicting tropism switch are still poorly understood. Limited longitudinal data are available to assess the influence that these factors have on predicting tropism switch and disease progression. The present study describes longitudinal tropism evolution in a group of recently HIV-infected individuals to determine the prevalence and potential correlates of tropism switch. We demonstrated here that a low baseline FPR determined by the Geno2pheno[coreceptor] algorithm can predict tropism evolution from CCR5 to CXCR4 coreceptor use.
Copyright © 2017 American Society for Microbiology.

Entities:  

Keywords:  coreceptor; disease progression; tropism switch

Mesh:

Substances:

Year:  2017        PMID: 28659473      PMCID: PMC5599763          DOI: 10.1128/JVI.00793-17

Source DB:  PubMed          Journal:  J Virol        ISSN: 0022-538X            Impact factor:   5.103


  74 in total

1.  Minimal requirements for the human immunodeficiency virus type 1 V3 domain to support the syncytium-inducing phenotype: analysis by single amino acid substitution.

Authors:  J J De Jong; A De Ronde; W Keulen; M Tersmette; J Goudsmit
Journal:  J Virol       Date:  1992-11       Impact factor: 5.103

Review 2.  Coreceptors and HIV-1 pathogenesis.

Authors:  Paul R Gorry; Petronela Ancuta
Journal:  Curr HIV/AIDS Rep       Date:  2011-03       Impact factor: 5.071

3.  Constitutive expression of stromal derived factor-1 by mucosal epithelia and its role in HIV transmission and propagation.

Authors:  W W Agace; A Amara; A I Roberts; J L Pablos; S Thelen; M Uguccioni; X Y Li; J Marsal; F Arenzana-Seisdedos; T Delaunay; E C Ebert; B Moser; C M Parker
Journal:  Curr Biol       Date:  2000-03-23       Impact factor: 10.834

4.  Cryptic nature of envelope V3 region epitopes protects primary monocytotropic human immunodeficiency virus type 1 from antibody neutralization.

Authors:  D C Bou-Habib; G Roderiquez; T Oravecz; P W Berman; P Lusso; M A Norcross
Journal:  J Virol       Date:  1994-09       Impact factor: 5.103

5.  Performance of a population-based HIV-1 tropism phenotypic assay and correlation with V3 genotypic prediction tools in recent HIV-1 seroconverters.

Authors:  Carmen de Mendoza; Kurt Van Baelen; Eva Poveda; Evelien Rondelez; Natalia Zahonero; Lieven Stuyver; Carolina Garrido; Jorge Villacian; Vincent Soriano
Journal:  J Acquir Immune Defic Syndr       Date:  2008-07-01       Impact factor: 3.731

6.  Detection of inferred CCR5- and CXCR4-using HIV-1 variants and evolutionary intermediates using ultra-deep pyrosequencing.

Authors:  Evelien M Bunnik; Luke C Swenson; Diana Edo-Matas; Wei Huang; Winnie Dong; Arne Frantzell; Christos J Petropoulos; Eoin Coakley; Hanneke Schuitemaker; P Richard Harrigan; Angélique B van 't Wout
Journal:  PLoS Pathog       Date:  2011-06-23       Impact factor: 6.823

7.  Reconstructing the dynamics of HIV evolution within hosts from serial deep sequence data.

Authors:  Art F Y Poon; Luke C Swenson; Evelien M Bunnik; Diana Edo-Matas; Hanneke Schuitemaker; Angélique B van 't Wout; P Richard Harrigan
Journal:  PLoS Comput Biol       Date:  2012-11-01       Impact factor: 4.475

8.  The genotypic false positive rate determined by V3 population sequencing can predict the burden of HIV-1 CXCR4-using species detected by pyrosequencing.

Authors:  Valentina Svicher; Valeria Cento; Gabriella Rozera; Isabella Abbate; Maria Mercedes Santoro; Daniele Armenia; Lavinia Fabeni; Alessandro Bruselles; Alessandra Latini; Guido Palamara; Valeria Micheli; Giuliano Rizzardini; Caterina Gori; Federica Forbici; Giuseppe Ippolito; Massimo Andreoni; Andrea Antinori; Francesca Ceccherini-Silberstein; Maria Rosaria Capobianchi; Carlo Federico Perno
Journal:  PLoS One       Date:  2013-01-14       Impact factor: 3.240

9.  MOSAIK: a hash-based algorithm for accurate next-generation sequencing short-read mapping.

Authors:  Wan-Ping Lee; Michael P Stromberg; Alistair Ward; Chip Stewart; Erik P Garrison; Gabor T Marth
Journal:  PLoS One       Date:  2014-03-05       Impact factor: 3.240

10.  Frequency and predictors of HIV-1 co-receptor switch in treatment naive patients.

Authors:  Virginie Mortier; Kenny Dauwe; Leen Vancoillie; Delfien Staelens; Filip Van Wanzeele; Dirk Vogelaers; Linos Vandekerckhove; Kristen Chalmet; Chris Verhofstede
Journal:  PLoS One       Date:  2013-11-07       Impact factor: 3.240

View more
  4 in total

1.  Transmission patterns of HIV-1 non-R5 strains in Poland.

Authors:  Joanna Smoleń-Dzirba; Magdalena Rosińska; Piotr Kruszyński; Janusz Janiec; Mariusz Cycoń; Jolanta Bratosiewicz-Wąsik; Marek Beniowski; Monika Bociąga-Jasik; Elżbieta Jabłonowska; Bartosz Szetela; Tomasz J Wąsik
Journal:  Sci Rep       Date:  2019-03-21       Impact factor: 4.379

Review 2.  HIV-1 subtype C predicted co-receptor tropism in Africa: an individual sequence level meta-analysis.

Authors:  Nontokozo D Matume; Denis M Tebit; Pascal O Bessong
Journal:  AIDS Res Ther       Date:  2020-02-07       Impact factor: 2.250

Review 3.  CCR5Δ32 in Brazil: Impacts of a European Genetic Variant on a Highly Admixed Population.

Authors:  Bruna Kulmann-Leal; Joel Henrique Ellwanger; José Artur Bogo Chies
Journal:  Front Immunol       Date:  2021-12-10       Impact factor: 7.561

4.  Nicotinamide activates latent HIV-1 ex vivo in ART suppressed individuals, revealing higher potency than the association of two methyltransferase inhibitors, chaetocin and BIX01294.

Authors:  Sadia Samer; Muhammad Shoaib Arif; Leila Bertoni Giron; Jean Paulo Lopes Zukurov; James Hunter; Bruna Teresa Santillo; Gislene Namiyama; Juliana Galinskas; Shirley Vasconcelos Komninakis; Telma Miyuki Oshiro; Maria Cecilia Sucupira; Luiz Mario Janini; Ricardo Sobhie Diaz
Journal:  Braz J Infect Dis       Date:  2020-02-24       Impact factor: 3.257

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.